Austere Pharma Life Science Ltd facility at UK, started its commercial production from 2005. The plant is in accordance with the guidelines of various international regulatory bodies like US-FDA, TGA, MHRA, MCC, WHO, ANVISA etc, which is the true testimony of Austere Life Science Ltd’s commitment towards quality and safety. Such standards helped Austere to attain strong footholds in the global market.
Infrastructure
Austere Pharma Life Science Ltd offers multiple production capabilities and high flexibility in all product categories Oral solids, Oral liquids, Sterile preparations (eye and ear) and Nasal preparations. The company has the adaptability to produce volumes from a pilot batch to commercial batches with consistent quality.
Our Products Molecules :